Doyle Mittie
Chief Medical Officer
CIK: 1918845
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 5,000 | $19.65 | $98,251.00 | View Details Filing |
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 10,058 | $22.88 | $230,127.04 | View Details Filing |
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 19,015 | $22.41 | $426,050.09 | View Details Filing |
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 44,944 | $21.20 | $952,668.98 | View Details Filing |
| May 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 27,538 | $18.03 | $496,405.50 | View Details Filing |
| May 5, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 1,679 | $16.00 | $26,864.00 | View Details Filing |
| Apr 6, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 3,970 | $18.01 | $71,508.43 | View Details Filing |
| Apr 1, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 679 | $16.00 | $10,864.00 | View Details Filing |
| Mar 16, 2026 | Avalo Therapeutics, Inc. (AVTX) | S | 25,492 | $16.15 | $411,606.58 | View Details Filing |